Skip to main content

Psoriasis clinical trials at UCSF

7 in progress, 5 open to eligible people

Psoriasis is a skin condition that causes red, scaly patches. UCSF is studying the immune response in psoriasis using treatments like deucravacitinib and guselkumab. Another trial looks at how sleep affects people with moderate to severe psoriasis. The impact of tildrakizumab on immune cells is also under investigation.

Showing trials for

Our lead scientists for Psoriasis research studies include .

Last updated: